What is changing in indications and treatment of hepatic hemangiomas. A review



Título del documento: What is changing in indications and treatment of hepatic hemangiomas. A review
Revista: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000412922
ISSN: 1665-2681
Autores: 1
2
3
4
5

6
7
Instituciones: 1Ospedale Taormina, Dipartimento di Chirurgia, Messina, Sicilia. Italia
2Hamad General Hospital, Department of Radiology, Doha City. Qatar
3Universita di Catania, Department of Medical and Pediatric Science, Catania, Sicilia. Italia
4Universita di Catania, International PhD Program in Neuropharmacology, Catania, Sicilia. Italia
5Ospedale Cannizzaro, Research Center "The Great Senescence", Catania, Sicilia. Italia
6Universita di Catania, Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, Catania, Sicilia. Italia
7Hamad Medical Hospital, Department of Surgery, Doha City. Qatar
Año:
Periodo: Jul-Ago
Volumen: 13
Número: 4
Paginación: 327-339
País: México
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Descriptivo
Resumen en inglés Hepatic cavernous hemangioma accounts for 73% of all benign liver tumors with a frequency of 0.4-7.3% at autopsy and is the second most common tumor seen in the liver after metastases. Patients affected by hemangioma usually have their tumor diagnosed by ultrasound abdominal examination for a not well defined pain, but pain persist after treatment of the hemangioma. The causes of pain can be various gastrointestinal pathologies including cholelithiasis and peptic ulcer disease.The malignant trasformation is pratically inexistent. Different imaging modalities are used to diagnosis liver hemangioma including ultrasonography, computed tomography (CT), magnetic resonance (MR) imaging, and less frequently scintigraphy, positronemission tomography combined with CT (PET/CT) and angiography. Imaging-guided biopsy of hemangioma is usually not resorted to except in extremely atypical cases. The right indications for surgery remain rupture, intratumoral bleeding, Kasabach-Merritt syndrome and organ or vessels compression (gastric outlet obstruction, Budd-Chiari syndrome, etc.) represents the valid indication for surgery and at the same time they are all complications of the tumor itself. The size of the tumor do not represent a valid indication for treatment. Liver hemangiomas, when indication exist, have to be treated firstly by surgery (hepatic resection or enucleation, open, laproscopic or robotic), but in the recent years other therapies like liver transplantation, radiofrequency ablation, radiotherapy, trans-arterial embolization, and chemotherapy have been applied
Disciplinas: Medicina
Palabras clave: Cirugía,
Gastroenterología,
Terapéutica y rehabilitación,
Hemangioma cavernoso,
Tumores benignos,
Ablación con radiofrecuencia,
Trasplantes
Keyword: Medicine,
Gastroenterology,
Surgery,
Therapeutics and rehabilitation,
Cavernous hemangioma,
Benign tumors,
Radiofrequency ablation,
Transplantation
Texto completo: Texto completo (Ver PDF)